Is Biotech Next?
As this market continues to broaden out, we're starting to see signs of rotation into areas that have been overlooked and underowned for a long time.
This is especially true for the rate-sensitive groups such as Builders, Banks, and Biotech.
Strazza calls them the Three B's.
And while the playbook is starting to work, we're not quite there yet.
We've seen some rotation into these names — especially Builders, which have caught a bid, and Banks, which are beginning to play catch-up.
Biotech still needs work.
However, that might be about to change.
Take a look at the Equal Weight Biotech ETF relative to the Equal Weight S&P 500.